Back

DIGIT­HF: Baseline characteristics compared to recent trials in heart failure with reduced ejection fraction

18 May 2025 (10:45 - 10:53)
Organised by: Logo
Congress Presentation Part of: Hottest trials and trial updates (2) Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Udo Bavendiek

Hannover Medical School, Hannover (Germany)

20 More presentations in this session

Presentation thumbnail
Discussant review - DIGIT­HF
Professor D. van Veldhuisen (Groningen, NL)
Slides Video
Presentation thumbnail
Panel discussion - DIGIT­HF
Video
Presentation thumbnail
CIRRUS­HCM: A multiple-dose phase 2 study of safety, tolerability, and effects on hemodynamics and functional capacity of the novel cardiac sarcomere modulator EDG-7500 in hypertrophic cardiomyopathy
Doctor A. Owens (Philadelphia, US)
Slides Video
Presentation thumbnail
Discussant review - CIRRUS­HCM
Professor I. Olivotto (Florence, IT)
Slides Video
Presentation thumbnail
Panel discussion - CIRRUS­HCM
Video

Access the full session

Session thumbnail
Hottest trials and trial updates (2)
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 10:45 CET
You may be interested in
thumbnail
Congress Presentation
DIGIT-HF: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
thumbnail
Congress Session
Hottest trials (2)
thumbnail
Congress Presentation
Discussant review - DIGIT-HF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources